Patients undergoing rehabilitation after proximal hip fracture
Conditions
Interventions
yoeito is administrated in patients with proximal hip fracture 4 weeks after surgery
Ninjin'
yoeito is not administrated in patients with proximal hip fracture after surgery
Sponsors
Nokami Kosei General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients after operation for hip fracture (osteosynthesis or femoral head prosthetic replacement) 2) Patients who planned or undergoing postoperative rehabilitation 3) Patients aged 65 years or older (when giving informed consent) 4) Patients who can take oral administrationof investigational drugs 5) Inpatients 6) Patients who are able to give written informed consent
Exclusion criteria
Exclusion criteria: Patients who have any of the following conditions are excluded. 1) Patients with severe mental disorders 2) Patients with severe complications for liver disease, kidney disease, heart disease, blood disease, autoimmune disease or metabolic disease, etc 3) Patients with malignant tumors or rheumatoid arthritis 4) Patients undergoing dialysis 5) Patients who take concomitant medications or investigational drugs within 2 weeks before starting this study 6) Patients who have a history of allergies or side effects in kampo 7) Patients who judged inappropriate for participation by investigators because they have other conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Independence Measure (FIM) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Weight loss rate 2) Nutritional indicators (serum albumin level, CONUT, GNRI, MNA-SF, dietary sufficiency rate) 3) Physical index (BMI,IBW) | — |
Countries
Japan
Contacts
Public ContactTAKUJI MATSUMOTO
Nokami Kosei General Hospital Department of Orthopedic Surgery
Outcome results
None listed